Merck & Co., Inc. news

   Watch this stock
Showing stories 1 - 10 of about 142   

Articles published

MRK 58.56 -0.26 (-0.44%)
price chart
Merck & Co., Inc. (NYSE:MRK) Looking To U.S. And Other Countries For ISENTRESS ...
Merck & Co., Inc. (NYSE:MRK) has said that it plans to seek approval for its once-daily formulation of Isentress (raltegravir) in the U.S.
Drug Manufacturers At Active Reaffirm Views- Merck & Co. Inc. (NYSE:MRK ...  Seneca Globe
Merck & Co. Inc. (NYSE:MRK)'s Damages Award for Infringement ...  Benchmark Monitor
Analyst Recommended Stock: Merck & Co. Inc. (NYSE:MRK)
The Company gained 0.05% and finished at $58.82. The daily volume was measured at 6.26 million shares. The 52-week high of the share price is $60.07 and the 52-week low is $45.69.
Key Stocks of the Day: Merck & Co. Inc. (NYSE:MRK)
As it reflects the theoretical cost of buying the company's shares, the market cap of Merck & Co. Inc. (NYSE:MRK) is currently rolling at 163166.68, making it one of the key stocks in today's market.
Upcoming Earnings Report: Merck & Co. Inc. (NYSE:MRK)
Merck & Co. Inc. (NYSE:MRK) increased 0.05% to reach at the trading price of $58.82 as it is set to share its next quarterly earnings on July 29, 2016.
Will Merck & Co. Inc. (NYSE:MRK) beat earning estimates again?  Zergwatch
HC Stocks Updates: Merck & Co., Inc. (NYSE:MRK) Ariad Pharmaceuticals, Inc ...
Shares of Merck & Co., Inc. (NYSE:MRK) ended Friday session in green amid volatile trading. The shares closed up +0.03 points or 0.05% at $58.82 with 6,269,481 shares getting traded.
Merck & Co. Inc. (NYSE:MRK) Went Up 0.05: Axovant Sciences Ltd. (NYSE:AXON ...
Merck & Co. Inc. (NYSE:MRK) traded 6.26 Million shares on last trading day with closing price of $58.82. Company gross margin stands at 62.80% whereas its return on investment (ROI) is 6.40%.
Better Buy: Merck & Co. Inc. vs. AbbVie
Among pharmaceutical companies, Merck & Co. (NYSE:MRK) and AbbVie (NYSE:ABBV) have been two of the most successful and profitable over the long run, and their share prices have posted impressive long-term returns for shareholders.
Stock buzz: Merck & Co., Inc. (NYSE:MRK)  Zergwatch
BMO Capital Markets Reiterates Outperform Rating for Merck & Co., Inc. (MRK)  Community Financial News
Stock's Movement in Target: Merck & Company, Inc. (NYSE:MRK), Spectrum ...
Merck & Company, Inc. (NYSE:MRK) initiated the shares trading at $58.99 and showed positive change of +0.05% while the stock's final trade was registered at $ 58.82.
Metropolitan Life Insurance Co. NY Has $78198000 Position in Merck & Co. (MRK)
Other institutional investors have also added to or reduced their stakes in the company. Oppenheimer & Co. Inc. boosted its position in Merck & Co. by 0.8% in the fourth quarter. Oppenheimer & Co. Inc. now owns 358,380 shares of the company's stock ...
Focusing on Analyst Predictions for Future EPS Growth Merck & Co. Inc. (NYSE:MRK)
Wall Street analysts are anticipating EPS growth for the next year of 0.81% for Merck & Co. Inc.(NYSE:MRK). For this year, the same analysts see an earnings per share change of -61.60%.